LAKE · XBRL financial data

Lakeland Industries financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (LAKE's year ends in late January)

In thousands of dollars	FY 2021Jan 31, 2021	FY 2022Jan 31, 2022	FY 2024Jan 31, 2024	FY 2023Apr 30, 2024	FY 2025Jan 31, 2025	FY 2026Jan 31, 2026
Revenue	159,000	118,386	124,688	6,300	167,211	192,648
Cost of revenue	79,750	67,473	73,496	—	98,537	129,322
Cost of goods and services sold	79,717	—	—	—	—	—
Gross profit	79,250	50,913	51,192	—	68,674	63,326
Research and development	200	—	—	—	—	—
Total operating expenses	35,397	34,866	45,200	—	67,401	76,990
Other operating income (expense)	—	121	3,415	—	—	—
Operating income (loss)	43,853	16,047	5,993	—	(9,265)	(15,512)
Interest expense	23	15	52	—	1,650	2,147
Other income (expense)	50	121	3,415	—	198	(40)
Income tax expense (benefit)	8,774	4,781	3,930	—	(281)	7,612
Net income (loss)	35,106	11,372	5,425	—	(18,075)	(25,311)
Earnings per share, basic USD per share	4.40	1.44	0.74	—	(2.43)	(2.63)
Earnings per share, diluted USD per share	4.31	1.41	0.72	—	(2.43)	(2.63)
Weighted average shares, basic thousands of shares	7,978	7,900	7,352	—	7,426	9,626
Weighted average shares, diluted thousands of shares	8,141	8,054	7,540	—	7,426	9,626

Fiscal years (LAKE's year ends in late January)

In thousands of dollars	FY 2021Jan 31, 2021	FY 2022Jan 31, 2022	FY 2024Jan 31, 2024	FY 2023Apr 30, 2024	FY 2025Jan 31, 2025	FY 2026Jan 31, 2026
Cash and cash equivalents	52,596	52,719	25,222	28,365	17,476	12,515
Short-term investments	—	—	2,161	—	—	—
Accounts receivable	21,702	14,771	19,169	21,763	27,607	32,043
Inventory	43,833	47,711	51,250	56,064	82,739	82,542
Prepaid and other current assets	329	—	—	—	—	—
Total current assets	123,609	120,646	101,505	113,768	136,531	134,186
Property and equipment, net	9,819	8,714	10,685	11,933	13,948	11,640
Right-of-use asset	2,347	5,296	10,969	12,080	13,917	11,248
Goodwill	871	871	13,669	15,215	16,240	15,287
Total assets	139,925	140,793	153,745	171,520	212,531	209,933
Accounts payable	7,397	5,855	7,378	9,051	15,742	15,565
Accrued liabilities	1,793	1,372	—	—	—	—
Current portion of long-term debt	0	0	—	—	939	1,891
Total current liabilities	15,394	12,015	18,346	21,096	34,907	37,962
Lease liability, non-current	1,613	3,678	9,121	10,236	10,681	10,264
Total liabilities	17,007	15,693	30,294	46,411	65,905	80,806
Retained earnings	52,687	62,892	69,282	70,714	50,320	23,857
Total stockholders' equity	122,918	125,100	123,450	125,109	146,626	129,127
Total liabilities and equity	139,925	140,793	153,745	171,520	212,531	209,933
Common shares outstanding (cover page) thousands of shares	8,027	8,556	7,372	7,325	9,499	10,723

Fiscal years (LAKE's year ends in late January)

In thousands of dollars	FY 2021Jan 31, 2021	FY 2022Jan 31, 2022	FY 2024Jan 31, 2024	FY 2023Apr 30, 2024	FY 2025Jan 31, 2025	FY 2026Jan 31, 2026
Net income (loss)	35,106	11,372	5,425	—	(18,075)	(25,311)
Stock-based compensation	1,727	1,667	1,365	—	1,558	3,391
Depreciation and amortization	1,965	1,868	2,111	—	2,600	2,800
Net cash from operating activities	40,666	12,782	10,912	—	(15,881)	(15,750)
Purchases of property and equipment	1,662	801	2,069	—	1,540	671
Net cash from investing activities	(1,662)	(3,584)	(5,116)	—	(47,742)	(1,184)
Dividends paid	—	—	908	—	887	1,152
Repayments of long-term debt	—	—	—	—	635	3,202
Net cash from financing activities	(1,277)	(9,805)	(3,452)	—	56,588	12,505
Net change in cash	37,990	123	583	—	(7,746)	(4,961)

SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Lakeland Industries	17,901	50,139	(404)*	9.9M	—	Q2 FY27 10-QJul 31, 2026
Picard Medical	38	2,954	(1,352)*	2.3M	0.0 quarters	Q2 FY26 10-QJun 30, 2026
Neuronetics	22,106	41,962	1,238*	77.7M	—	Q3 FY26 10-QSep 30, 2026
AVITA Medical	9,139	21,702	(3,496)*	30.9M	3.2 quarters	Q2 FY26 10-QJun 30, 2026
InfuSystem Holdings	964	36,933	6,777*	19.9M	—	Q2 FY26 10-QJun 30, 2026
KORU Medical Systems	8,288	12,045	216*	46.2M	—	Q2 FY26 10-QJun 30, 2026
Anika Therapeutics	38,412	32,610	(684)*	13.4M	56.2 quarters	Q2 FY26 10-QJun 30, 2026
Sanara MedTech	15,421	28,137	2,038*	9.2M	—	Q2 FY26 10-QJun 30, 2026
Stereotaxis	10,491	7,670	(3,675)*	100.2M	2.9 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.